Gerlach J, Korsgaard S, Clemmesen P, Lauersen A M, Magelund G, Noring U, Povlsen U J, Bech P, Casey D E
Department P, St. Hans Hospital, Roskilde, Denmark.
Acta Psychiatr Scand. 1993 Apr;87(4):244-52. doi: 10.1111/j.1600-0447.1993.tb03366.x.
The St. Hans Rating Scale (SHRS) is a multidimensional rating scale for the evaluation of neuroleptic-induced hyperkinesia, parkinsonism, akathisia and dystonia. This scale and the Abnormal Involuntary Movement Scale (AIMS) were tested by 7 raters (2 experienced, 2 less experienced and 3 totally inexperienced) in 30 psychiatric patients with tardive dyskinesia (TD). The test was performed 3 times in the same patients: 1) live evaluation during a video recording, 2) evaluation 2 weeks later from the videotape, and 3) evaluation after another 2 weeks from the same videotape. The intrarater reliability was high in the experienced group (0.91-0.96 for SHRS hyperkinesia scale, 0.80-0.84 for AIMS, and 0.82-0.97 for SHRS total parkinsonism). No significant changes occurred from live to video evaluation. The interrater reliability coefficient for the experienced group was also high: 0.89-0.95 for the SHRS hyperkinesia scale, 0.76-0.85 for the AIMS scale and 0.95-0.98 for the SHRS parkinsonism scale. The less experienced and the inexperienced raters had coefficients for intra- and interrater reliability that were 0.10 and 0.20 lower, respectively. The SHRS parkinsonism scale had a high construct validity, as determined by the homogeneity coefficients of Cronbach (0.82) and Loevinger (0.43). The corresponding coefficients for the hyperkinesia scales were low, in agreement with the individual distribution of TD (only about 50% present extremity dyskinesia and less than 25% facial, head and trunk dyskinesia, independent of the severity of the syndrome). Finally, convergent validity was found between the SHRS hyperkinesia scale and AIMS and divergent validity between all of the other scales.(ABSTRACT TRUNCATED AT 250 WORDS)
圣汉斯评定量表(SHRS)是一种用于评估抗精神病药物所致运动亢进、帕金森症、静坐不能和肌张力障碍的多维评定量表。7名评定者(2名经验丰富、2名经验较少和3名完全无经验)对30例迟发性运动障碍(TD)精神病患者使用该量表及异常不自主运动量表(AIMS)进行测试。在同一患者身上进行了3次测试:1)视频记录时的现场评估;2)两周后通过录像带评估;3)再过两周后通过同一录像带评估。经验丰富组的评定者内部信度较高(SHRS运动亢进量表为0.91 - 0.96,AIMS为0.80 - 0.84,SHRS帕金森症总量表为0.82 - 0.97)。从现场评估到视频评估未发生显著变化。经验丰富组的评定者间信度系数也较高:SHRS运动亢进量表为0.89 - 0.95,AIMS量表为0.76 - 0.85,SHRS帕金森症量表为0.95 - 0.98。经验较少和无经验的评定者的评定者内部和评定者间信度系数分别低0.10和0.20。根据克朗巴赫(0.82)和洛温杰(0.43)的同质性系数,SHRS帕金森症量表具有较高的结构效度。运动亢进量表的相应系数较低,这与TD的个体分布一致(仅约50%存在肢体运动障碍,面部、头部和躯干运动障碍不到25%,与综合征严重程度无关)。最后,发现SHRS运动亢进量表与AIMS之间具有收敛效度,而其他所有量表之间具有发散效度。(摘要截于250字)